Heidelberg Pharma AG based in Ladenburg, Germany, is a biopharmaceutical company listed on the Frankfurt Stock Exchange in the Regulated Market / Prime Standard. The Company was founded in September 1997 by a team of physicians and oncologists from the Technical University of Munich. In 2000, the Company changed to an AG from a GmbH legal structure. In 2011, the subsidiary Heidelberg Pharma Research GmbH was acquired.
Heidelberg Pharma was restructured in 2014, which led to the discontinuation of all research and development activities in Munich. The shareholder’s meeting in July 2017 decided to move the registered office of WILEX AG from Munich to Ladenburg and to change the name of the Company to Heidelberg Pharma AG. The subsidiary Heidelberg Pharma GmbH is now named Heidelberg Pharma Research GmbH.
Gregor-Mendel-Straße 22, 68526 Ladenburg – Germany
|Date||Trading entity / Person||Association||Trade type||Volume|
|13.10.22||4H invest GmbH||Close relation||Other||EUR 993,666.24|
|13.10.22||Bohlini invest GmbH||Close relation||Other||EUR 964,061.56|
|13.10.22||MH-LT-Investments GmbH||Close relation||Other||EUR 506,241.96|
|13.10.22||Schneiders, Michael||Board||Buy||EUR 13,088.40|
|13.10.22||Schneiders, Michael||Board||Buy||EUR 4,895.60|
|07.09.22||Plate, Achim||Board||Buy||EUR 30,869.92|
|06.09.22||Kudlek, Dr. Birgit||Supervisory board||Other||EUR 7,496.16|
|22.03.22||4H invest GmbH||Close relation||Other||EUR 0.00|
|16.03.22||WAOW entrepreneurship GmbH||Close relation||Buy||EUR 494,208.00|
|16.03.22||Beretti, Giulio||Other||Buy||EUR 4,025.00|
Stifel Europe Bank AGListed Stock Exchange
Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.